SCHEMBL14999941

SCHEMBL14999941

CCCCC(C(=O)NS(=O)(=O)c1ccc2ccccc2c1)C(=O)N(CC)CC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LARS1 Q9P2J5 1/20 0.53
MMP1 P03956 1/20 0.50
MMP7 P09237 1/20 0.50
ACE P12821 1/20 0.50
MMP12 P39900 1/20 0.50
MMP13 P45452 1/20 0.50
RAPGEF3 O95398 1/20 0.43
ALDH1A1 P00352 4/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NLRP3 Q96P20 1/20 0.43
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
F2 P00734 1/20 0.41
HTR6 P50406 1/20 0.41
F10 P00742 1/20 0.41
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13151623 0.89 LARS1 (0.57) LARS1RAPGEF3ALDH1A1L3MBTL1NLRP3
SCHEMBL3080656 0.87 LARS1 (0.58) LARS1MMP1MMP7ACEMMP12
SCHEMBL15000037 0.87 LARS1 (0.49) LARS1ALDH1A1KDM4EF2F10
SCHEMBL14999952 0.86 LARS1 (0.50) LARS1MMP1MMP7ACEMMP12
SCHEMBL15000276 0.84 LARS1 (0.53) LARS1MMP1MMP13RAPGEF3ALDH1A1
SCHEMBL3085973 0.84 LARS1 (0.53) LARS1RAPGEF3ALDH1A1L3MBTL1NLRP3
SCHEMBL15000148 0.84 LARS1 (0.45) LARS1ALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL15000274 0.83 LARS1 (0.52) LARS1RAPGEF3ALDH1A1L3MBTL1NLRP3
SCHEMBL15000268 0.83 LARS1 (0.50) LARS1ALDH1A1KDM4EF2LMNA
SCHEMBL3084604 0.82 LMNA (0.44) LARS1KDM4ELMNASMN1; SMN2KAT6A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461209-B2 Malonic acid sulfonamide derivative and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-06-11 US disclosed